Back

Care Home Residence and Carbapenemase-Producing Enterobacterales Positivity: A Matched Case-Control Study

Owhotake, H.; Ashlin, J.; Oggiano, S.; Plant, A. J.

2026-07-06 infectious diseases
10.64898/2026.07.02.26357111 medRxiv
Show abstract

Background: Carbapenemase producing Enterobacterales (CPE) remain a major infection prevention and control challenge. Although care home residence is frequently perceived as a risk factor for CPE carriage, its independent association with CPE positivity remains uncertain. Objective: To investigate the relationship between care home residence on admission and CPE positivity among patients undergoing CPE screening. Methods: A retrospective matched case control study was conducted at a single NHS acute hospital in England. Adult patients with laboratory confirmed CPE positivity from screening samples between 1 November 2022 and 1 November 2025 were matched to CPE negative controls at a ratio of up to 1:4 based on ward, specimen year and age no more than 5 years older or younger. Conditional logistic regression was used to assess the association between care home residence and CPE positivity. An adjusted model included previous hospital admission within 12 months. Results: A total of 108 CPE positive cases were successfully matched to 412 controls. Care home residence was identified in 14 (13.0%) cases and 49 (11.9%) controls. In the matched conditional logistic regression model, care home residence was not associated with CPE positivity (OR 1.15, 95% CI 0.58 to 2.28; p=0.690) and remained non-significant after adjustment (aOR 1.32, 95% CI 0.66 to 2.64; p=0.439). Discussion: Care home residence was not independently associated with CPE positivity in this low-prevalence setting. Significance and impact: The findings do not support the use of care home residence alone to guide CPE screening. Further multicentre studies are required to clarify the contribution of care home residence to CPE epidemiology.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Journal of Antimicrobial Chemotherapy
46 papers in training set
Top 0.1%
18.4%
2
BMC Infectious Diseases
133 papers in training set
Top 0.1%
7.8%
3
Antimicrobial Resistance & Infection Control
11 papers in training set
Top 0.1%
7.2%
4
Journal of Hospital Infection
29 papers in training set
Top 0.1%
6.2%
5
PLOS ONE
5266 papers in training set
Top 28%
5.5%
6
Open Forum Infectious Diseases
142 papers in training set
Top 0.4%
5.4%
50% of probability mass above
7
Journal of Infection
78 papers in training set
Top 0.1%
5.4%
8
Journal of Medical Microbiology
25 papers in training set
Top 0.2%
2.8%
9
The Lancet Infectious Diseases
73 papers in training set
Top 0.6%
2.1%
10
Microbial Genomics
225 papers in training set
Top 2%
1.7%
11
Wellcome Open Research
67 papers in training set
Top 0.7%
1.7%
12
Microbiology Spectrum
469 papers in training set
Top 7%
1.7%
13
Clinical Infectious Diseases
235 papers in training set
Top 2%
1.5%
14
Infection Control & Hospital Epidemiology
17 papers in training set
Top 0.1%
1.5%
15
The Lancet Microbe
44 papers in training set
Top 0.5%
1.4%
16
JAC-Antimicrobial Resistance
14 papers in training set
Top 0.3%
1.3%
17
Age and Ageing
28 papers in training set
Top 0.3%
1.3%
18
Eurosurveillance
83 papers in training set
Top 0.7%
1.1%
19
BMJ Open
601 papers in training set
Top 11%
1.1%
20
Nature Communications
5641 papers in training set
Top 51%
1.1%
21
The Lancet
16 papers in training set
Top 0.2%
1.0%
22
Emerging Infectious Diseases
105 papers in training set
Top 1%
1.0%
23
Scientific Reports
3612 papers in training set
Top 71%
1.0%
24
The Journal of Infectious Diseases
202 papers in training set
Top 4%
0.9%
25
PLOS Neglected Tropical Diseases
466 papers in training set
Top 5%
0.9%
26
BMJ Public Health
25 papers in training set
Top 1%
0.8%
27
Epidemiology and Infection
89 papers in training set
Top 3%
0.6%
28
Journal of the American Medical Directors Association
13 papers in training set
Top 0.4%
0.6%